logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
28/03/2026
Bahraini Defence Forces: Intercepted and destroyed 20 missiles and 23 drones in the last 24 hours.
Latest
7 m ago
Saudi Arabia: Intercepts two drones in the past few hours.
7 m ago
The "Online Sales Product Quality and Safety Enhancement Series Action 2026" was launched in Beijing.
8 m ago
Standard Stock: Strategic cooperation with Ankang College and Shaanxi Textile Industry Association.
11 m ago
Iran claims that drones have carried out a large-scale attack on Israeli targets.
11 m ago
According to the AI Fast News of Every Macro, Dongwu Securities issued a research report on March 28, giving Lijiu Group (000513.SZ) a "buy" rating. The rating reasons mainly include: 1) the biological products, traditional Chinese medicine sector, and overseas growth rate are good by 2025, and the overall performance meets expectations; 2) the layout of innovative drugs and biopharmaceutical pipeline is accelerating, with single products worth more than 1 billion yuan being listed one after another. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.